The Economic Times
May 07, 2001

Sami Labs plans to set up research demo farm.

 

BANGALORE – based Sami Labs, a 100 per export oriented unit plans to set up a 100 acre research demonstration farm at an investment of around Rs.3 crore by the end of this year.

According to Dr. Muhammed Majeed, Managing Director Sami Labs, the company also plans to enhance its biotech activities which it commenced last year and is looking at drug development from natural products and herbal formulations in big way.

"At present, Sami Labs is in the advanced stage of discussion with MNCs for strategic alliance in the areas of biotechnology and nurtaceuticals," he added.

As a first step towards this, the company has tied up the Neeja Pharmaceuticals, Canada for the development of a new generation antibiotic which is awaiting patent clearance in India.

Also Sami Labs plans to set up biotech incubator with seed capital for promising biotech entrepreneurs in Bangalore.

"This will be a boon to small startups which are not able to commence operations for want of funds", said Dr. Majeed.

Sami Labs, which manufacturers and markets plant extracts for pharmaceutical intermediates, has allocated Rs.50 crore for biotech activities besides other related drug development operations to produce probotics, an oil eating bacteria. The company has also identified a new molecule which increases skin permeability.

The company has set up four manufacturing plants in Karnataka at Singasandara, Kunigal, Mysore and at Nelamangala (biotech centre) at an investment of Rs.35 crore.

Anil Urs